Acceleron to Host Conference Call and Webcast to Review Data Presented at the 61st American Society of Hematology Annual Meeting
Rami Komrokji, M.D., Senior Member & Professor of Oncologic Sciences, Section Head- Leukemia and MDS,
Vice Chair-Malignant Hematology Department, Moffitt Cancer Center, Tampa, Florida
Thomas Coates, M.D., Professor of Pediatrics and Pathology, Division of Hematology/ Oncology, Children’s Hospital Los Angeles, University of Southern California
Srdan Verstovsek, M.D., Ph.D., Professor,
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas
The webcast will be accessible under "Events & Presentations" in the Investors & Media page of the company's website at www.acceleronpharma.com. Individuals can participate in the conference call by dialing 877-312-5848 (domestic) or 253-237-1155 (international) and refer to the “Acceleron ASH 2019 Conference Call.”
The archived webcast will be available for replay on the Acceleron website approximately two hours after the event.
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. The Company's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Acceleron focuses its research and development efforts in hematologic, neuromuscular, and pulmonary diseases. In hematology, the Company and its global collaboration partner,
Acceleron Pharma Inc.
Todd James, IRC, 617-649-9393
Vice President, Investor Relations and Corporate Communications
Ed Joyce, 617-649-9242
Director, Investor Relations
Matt Fearer, 617-301-9557
Director, Corporate Communications